| 000 | 01793 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518033924.0 | ||
| 264 | 0 | _c20200915 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1473-1150 | ||
| 024 | 7 |
_a10.1038/s41397-019-0086-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTague, Laneshia K | |
| 245 | 0 | 0 |
_aImpact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c02 2020 |
||
| 300 |
_a69-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAllografts _xdrug effects |
| 650 | 0 | 4 |
_aAzathioprine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 |
_aLung Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aSolute Carrier Organic Anion Transporter Family Member 1B3 _xgenetics |
| 650 | 0 | 4 | _aTransplant Recipients |
| 700 | 1 | _aByers, Derek E | |
| 700 | 1 | _aHachem, Ramsey | |
| 700 | 1 | _aKreisel, Daniel | |
| 700 | 1 | _aKrupnick, Alexander S | |
| 700 | 1 | _aKulkarni, Hrishikesh S | |
| 700 | 1 | _aChen, Catherine | |
| 700 | 1 | _aHuang, Howard J | |
| 700 | 1 | _aGelman, Andrew | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 20 _gno. 1 _gp. 69-79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41397-019-0086-0 _zAvailable from publisher's website |
| 999 |
_c29595985 _d29595985 |
||